Status: Not yet recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception
This is a multicenter, open-label, Phase 2b study to evaluate the efficacy and safety of 2 LB SQ injections administered at a 4-month (approximately 17 weeks) interval for female contraception.
Participants needed: 165
Trial details
Phase: Phase 2Age: 18-35Biological sex: FemaleType: InterventionalSponsor: Premier ResearchUpdated: Oct 29, 2025
Eligibility criteria
Participant understands and signs an ICF approved by the institutional review bo... [+12]
Planning pregnancy during study participation through the End -of -Treatment Vis... [+28]